Pick Aurobindo Pharma, target Rs 770-780: Hemant Thukral

Hemant Thukral of Aditya Birla Money told CNBC-TV18, "I think pharma will remain the sector of the next series specially the midcap pharmaceutical stocks. They are seeing exceptional rollovers right now, whether it is Strides Arcolab or Wockhardt. I have picked Aurobindo Pharma for two reasons, one is the rollover has already reached 80 percent. I am expecting it to cross 90 percent rollover. Technically this stock is now very easily trading above Rs 735-740 mark. So I am expecting it to go up to Rs 770-780 and we are keeping a stop loss of Rs 715-720 on the same."At 12:07 hrs Aurobindo Pharma was quoting at Rs 738.00, up Rs 4.85, or 0.66 percent. It has touched an intraday high of Rs 741.20 and an intraday low of Rs 729.05.